Frost edit · Free shipping over $70 · Cool essentials
merck glp-1 drug

merck glp-1 drug pays $112M upfront for Hansoh's preclinical Green List by FDA To

SKU: 76341310154
4.5
USD29.33 USD60.33

Pay in 4 interest-free payments of $7.33 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

Before this approval, generic liraglutide was only approved to treat people with Type 2 diabetes, as a generic version of brand-name Victoza

merck glp-1 drug pays $112M upfront for Hansoh's preclinical Green List by FDA To

With healthcare expenditure increasing and awareness rising, Asia Pacific is expected to be a major growth driver through 2030

merck glp-1 drug pays $112M upfront for Hansoh's preclinical Green List by FDA To

By February 21, 2020, dodecaplatin (dulaglutide) is the first and only FDA-approved anti-diabetic drug for primary and secondary prevention to alleviate the risk of MACE [25]

merck glp-1 drug pays $112M upfront for Hansoh's preclinical Green List by FDA To

Aronne, L

merck glp-1 drug pays $112M upfront for Hansoh's preclinical Green List by FDA To
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products